In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lungpacer Medical Inc.

Latest From Lungpacer Medical Inc.

CDRH's Expedited Access Pathway: 17 Devices And Counting

A system using nerve stimulation to treat diaphragm atrophy in mechanical ventilation patients is the latest product to be granted EAP designation. FDA officials recently confirmed that 17 devices have been accepted to the expedited development pathway about a year after the program launched.

Medical Device Regulation

Selected Start-Ups (01/2010)

In Vivo briefly describes these recently founded companies: Acton Pharmaceuticals, AesRx, Lungpacer Medical, MAX Endoscopy, OtoKinetics and Thermalin Diabetes.
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Lungpacer Medical Inc.
  • Senior Management
  • Andy Hoffer, PhD, Pres. & CSO
  • Contact Info
  • Lungpacer Medical Inc.
    Phone: (778) 782-3141
    K-9625 Shrum Science Ctr., Simon Fraser
    8888 Univ. Dr.
    Burnaby, V5A 1S6